TTN and neoplasm: Results revealed that in both the CT26 model in BALB/c mice and the immunocompetent C57BL/6 mouse model with MC38 cells, tumours with TTN‐KO exhibited decreased growth rates compared with the WT group, which further decreased in growth rate when combined with radiotherapy (Figure S7).